Barr Laboratories News

The latest "problem drug" TV commercials about Yaz, Yasmin and Ocella - " which are known to cause blood clots, strokes and even death in some women - " have been tough to miss.

Cephalon Inc. will give Barr Pharmaceuticals Inc. a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a Securities and Exchange Commission filing Thursday.

Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc.

Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, announced today that its subsidiary Watson Laboratories, Inc.

Sales of the Plan B "morning-after pill" nearly doubled in the past year, exceeding expectations after the U.S. government allowed adults to buy the emergency contraceptive without a prescription.

Shire plc , the global specialty biopharmaceutical company, announces that it has settled all pending litigation with Sandoz, Inc.

MORRISTOWN, N.J. A generic pharmaceutical company has appointed a new executive to its branded drug division.

Our office is investigating claims of injury related to the birth control pills known as Yaz or Yasmin: Yasmin and Yaz are two types of birth control pills manufactured by Bayer Healthcare, and the generic, Ocella, is marketed and distributed by Barr Laboratories, Inc.

The following recalls have been announced: _ Barr Laboratories Inc. is recalling 100-count bottles of 20-milligram tablets of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate with lot number 311756.

Barr Laboratories has recalled a single lot of a mixed-amphetamine product because some tablets may contain more drug than specified.

Barr Laboratories, Inc. is initiating a voluntary recall of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 20mg Tablets, 100 count bottles, lot number 311756.

Barr Laboratories, Inc. is initiating a voluntary recall of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate 20mg Tablets, 100 count bottles, lot number 311756.

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No.

Aug 5, 2009 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No.

Aug 5, 2009 - Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No.

Teva Pharmaceutical Industries Ltd. announced today that the U.S. Court of Appeals for the Federal Circuit has affirmed a ruling by the U.S. District Court for the District of New Jersey finding Bayer Schering's U.S. Patent No.

Perrigo Company today announced that its partner Teva Pharmaceutical Industries Ltd.

Perrigo Company today announced that its partner Teva Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries said Tuesday second-quarter profit rose 25 percent on revenue from its top-selling multiple sclerosis drug Copaxone and savings from the acquisition of Barr Pharmaceuticals.

I keep waiting for Teva Pharmaceuticals to falter. The company has been on a tear -- already up 21% year to date, handily beating the S&P500. It has to pause at some point, doesn't it? That day won't be today.